Journal of Clinical Lipidology Sees Significant Increase in Impact Factor

The 2013 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw a significant increase — from 2.741 (2012) to 3.587. The Journal is now ranked 53rd out of 254 journals in its category (pharmacology and pharmacy). 

“This a very large change in one year and we should all be pleased,” says W. Virgil Brown, MD, FNLA, Editor-in-Chief of the JCL. “It has been a team effort. The NLA has been a tremendous help with the review articles and position statements. These, plus Elsevier's strong support, have made my job easy. Thanks to all who have worked on publications and enriched our Journal.”

The Thomson-Reuters Impact Factor represents the ratio of articles quoted in other scientific publications compared to the total qualifying articles during the years 2012 and 2013.